Palmetto Partners 2014, LP is 10% Owner at XERIS PHARMACEUTICALS INC (XERS). They have made 1 open-market trade across 1 company since 2018, most recently 2018-06-25.
CIK 0001744227
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.3M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XERS | 930,383 | $9.6M |
Shares reported on the most recent Form 4, priced at the 2018-06-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XERS | BUY | 2018-06-25 | 2018-06-25 | $15.00 | $2.3M | -11.1% | -2.6% | -4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.